» Articles » PMID: 27220847

Substrate Recruitment of γ-secretase and Mechanism of Clinical Presenilin Mutations Revealed by Photoaffinity Mapping

Overview
Journal EMBO J
Date 2016 May 26
PMID 27220847
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Intramembrane proteases execute fundamental biological processes ranging from crucial signaling events to general membrane proteostasis. Despite the availability of structural information on these proteases, it remains unclear how these enzymes bind and recruit substrates, particularly for the Alzheimer's disease-associated γ-secretase. Systematically scanning amyloid precursor protein substrates containing a genetically inserted photocrosslinkable amino acid for binding to γ-secretase allowed us to identify residues contacting the protease. These were primarily found in the transmembrane cleavage domain of the substrate and were also present in the extramembranous domains. The N-terminal fragment of the catalytic subunit presenilin was determined as principal substrate-binding site. Clinical presenilin mutations altered substrate binding in the active site region, implying a pathogenic mechanism for familial Alzheimer's disease. Remarkably, PEN-2 was identified besides nicastrin as additional substrate-binding subunit. Probing proteolysis of crosslinked substrates revealed a mechanistic model of how these subunits interact to mediate a stepwise transfer of bound substrate to the catalytic site. We propose that sequential binding steps might be common for intramembrane proteases to sample and select cognate substrates for catalysis.

Citing Articles

Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis.

Area-Gomez E, Schon E J Alzheimers Dis. 2024; 98(4):1243-1275.

PMID: 38578892 PMC: 11091651. DOI: 10.3233/JAD-231318.


Nonallosteric activation of posttranslational modification enzymes by active site-directed inhibitors.

Pesaresi A Comput Struct Biotechnol J. 2023; 23:34-42.

PMID: 38089466 PMC: 10711399. DOI: 10.1016/j.csbj.2023.11.019.


Interaction of Substrates with γ-Secretase at the Level of Individual Transmembrane Helices-A Methodological Approach.

Pauli T, Julius A, Costa F, Eschrig S, Moosmuller J, Fischer L Int J Mol Sci. 2023; 24(18).

PMID: 37762696 PMC: 10531681. DOI: 10.3390/ijms241814396.


Alzheimer's Disease: Significant Benefit from the Yeast-Based Models.

Epremyan K, Mamaev D, Zvyagilskaya R Int J Mol Sci. 2023; 24(12).

PMID: 37372938 PMC: 10298092. DOI: 10.3390/ijms24129791.


Different transmembrane domains determine the specificity and efficiency of the cleavage activity of the γ-secretase subunit presenilin.

Schmidt F, Fitz K, Feilen L, Okochi M, Steiner H, Langosch D J Biol Chem. 2023; 299(5):104626.

PMID: 36944398 PMC: 10164903. DOI: 10.1016/j.jbc.2023.104626.


References
1.
Capell A, Saffrich R, Olivo J, Meyn L, Walter J, Grunberg J . Cellular expression and proteolytic processing of presenilin proteins is developmentally regulated during neuronal differentiation. J Neurochem. 1997; 69(6):2432-40. DOI: 10.1046/j.1471-4159.1997.69062432.x. View

2.
De Strooper B, Gutierrez L . Learning by failing: ideas and concepts to tackle γ-secretases in Alzheimer's disease and beyond. Annu Rev Pharmacol Toxicol. 2014; 55:419-37. DOI: 10.1146/annurev-pharmtox-010814-124309. View

3.
Struhl G, GREENWALD I . Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature. 1999; 398(6727):522-5. DOI: 10.1038/19091. View

4.
Weggen S, Beher D . Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease. Alzheimers Res Ther. 2012; 4(2):9. PMC: 3334542. DOI: 10.1186/alzrt107. View

5.
Dries D, Shah S, Han Y, Yu C, Yu S, Shearman M . Glu-333 of nicastrin directly participates in gamma-secretase activity. J Biol Chem. 2009; 284(43):29714-24. PMC: 2785603. DOI: 10.1074/jbc.M109.038737. View